$PEN
Penumbra Inc Stock $pen

$pen Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000132173216000089 Filed on November 03, 2016

Income Statement

Concept	2016 Q3	2015 Q3
Revenue	$67.19M	$50.42M
YoY Change	33.27%	55.3%
Cost Of Revenue	$24.31M	$16.92M
YoY Change	43.7%	45.02%
Gross Profit	$42.87M	$33.50M
YoY Change	27.99%	61.07%
Gross Profit Margin	63.81%	66.44%
Selling, General & Admin	$37.74M	$26.76M
YoY Change	41.06%	61.28%
% of Gross Profit	88.03%	79.87%
Research & Development	$6.497M	$4.560M
YoY Change	42.48%	17.01%
% of Gross Profit	15.15%	13.61%
Depreciation & Amortization	$700.0K	$500.0K
YoY Change	40.0%	150.0%
% of Gross Profit	1.63%	1.49%
Operating Expenses	$44.24M	$31.32M
YoY Change	41.26%	52.86%
Operating Profit	-$1.363M	$2.182M
YoY Change	-162.47%	601.61%
Interest Expense	$631.0K	$17.00K
YoY Change	3611.76%	-88.19%
% of Operating Profit		0.78%
Other Income/Expense, Net	-$360.0K	-$115.0K
YoY Change	213.04%	105.36%
Pretax Income	-$1.092M	$2.084M
YoY Change	-152.4%	422.31%
Income Tax	-$13.00M	$1.183M
% Of Pretax Income		56.77%
Net Earnings	$11.91M	$901.0K
YoY Change	1221.42%	423.84%
Net Earnings / Revenue	17.72%	1.79%
Basic Earnings Per Share	$0.39	$0.04
Diluted Earnings Per Share	$0.35	$0.03
COMMON SHARES
Basic Shares Outstanding	30.60M shares	7.854M shares
Diluted Shares Outstanding	33.76M shares	10.19M shares

Balance Sheet

Concept	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$141.8M	$159.1M
YoY Change	-10.87%
Cash & Equivalents	$15.86M	$159.1M
Short-Term Investments	$126.0M	$0.00
Other Short-Term Assets	$5.004M	$177.0K
YoY Change	2727.12%
Inventory	$70.09M	$50.32M
Prepaid Expenses	$5.236M	$5.772M
Receivables	$36.64M	$26.06M
Other Receivables	$5.100M	$300.0K
Total Short-Term Assets	$267.8M	$249.1M
YoY Change	7.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.22M	$8.646M
YoY Change	87.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$438.0K	$293.0K
YoY Change	49.49%
Total Long-Term Assets	$38.72M	$10.25M
YoY Change	277.84%
TOTAL ASSETS
Total Short-Term Assets	$267.8M	$249.1M
Total Long-Term Assets	$38.72M	$10.25M
Total Assets	$306.5M	$259.3M
YoY Change	18.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.584M	$4.024M
YoY Change	-10.93%
Accrued Expenses	$33.76M	$24.25M
YoY Change	39.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$37.34M	$28.28M
YoY Change	32.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.540M	$2.458M
YoY Change	125.39%
Total Long-Term Liabilities	$5.540M	$2.458M
YoY Change	125.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$37.34M	$28.28M
Total Long-Term Liabilities	$5.540M	$2.458M
Total Liabilities	$42.88M	$30.74M
YoY Change	39.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$264.0K	-$19.11M
YoY Change	-98.62%
Common Stock	$31.00K	$30.00K
YoY Change	3.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$263.6M	$228.6M
YoY Change
Total Liabilities & Shareholders Equity	$306.5M	$259.3M
YoY Change	18.19%

Cashflow Statement

Concept	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$11.91M	$901.0K
YoY Change	1221.42%	423.84%
Depreciation, Depletion And Amortization	$700.0K	$500.0K
YoY Change	40.0%	150.0%
Cash From Operating Activities	$5.730M	-$4.300M
YoY Change	-233.26%	44.3%
INVESTING ACTIVITIES
Capital Expenditures	-$3.380M	-$1.440M
YoY Change	134.72%	46.94%
Acquisitions
YoY Change
Other Investing Activities	-$440.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$3.820M	-$1.440M
YoY Change	165.28%	-96.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.220M	128.2M
YoY Change	-99.05%	-1764.42%
NET CHANGE
Cash From Operating Activities	5.730M	-4.300M
Cash From Investing Activities	-3.820M	-1.440M
Cash From Financing Activities	1.220M	128.2M
Net Change In Cash	3.130M	122.4M
YoY Change	-97.44%	-357.35%
FREE CASH FLOW
Cash From Operating Activities	$5.730M	-$4.300M
Capital Expenditures	-$3.380M	-$1.440M
Free Cash Flow	$9.110M	-$2.860M
YoY Change	-418.53%	43.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-59000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5071000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-672000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0001321732
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6865000	USD
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31643863	shares
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-346000	USD
	dei	Entity Registrant Name EntityRegistrantName	Penumbra Inc
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-733000	USD
CY2015Q4	pen	Accrued Capital Expenditures And Leasehold Improvements Current AccruedCapitalExpendituresAndLeaseholdImprovementsCurrent	0	USD
CY2016Q3	pen	Accrued Capital Expenditures And Leasehold Improvements Current AccruedCapitalExpendituresAndLeaseholdImprovementsCurrent	2093000	USD
CY2015Q4	pen	Allowancefor Sales Returns Current AllowanceforSalesReturnsCurrent	3247000	USD
CY2016Q3	pen	Allowancefor Sales Returns Current AllowanceforSalesReturnsCurrent	2995000	USD
CY2015Q4	pen	Clinical Trial Accruals Current ClinicalTrialAccrualsCurrent	1330000	USD
CY2016Q3	pen	Clinical Trial Accruals Current ClinicalTrialAccrualsCurrent	2195000	USD
	pen	Numberof Business Activities NumberofBusinessActivities	1	activity
	pen	Productsand Services Numberof Markets ProductsandServicesNumberofMarkets	2	market
CY2015	pen	Standardand Extended Product Warranty Accrual Increase Decreasefor Changesin Estimatefor Newand Preexisting Warranties StandardandExtendedProductWarrantyAccrualIncreaseDecreaseforChangesinEstimateforNewandPreexistingWarranties	752000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2115000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3592000	USD
	pen	Standardand Extended Product Warranty Accrual Increase Decreasefor Changesin Estimatefor Newand Preexisting Warranties StandardandExtendedProductWarrantyAccrualIncreaseDecreaseforChangesinEstimateforNewandPreexistingWarranties	894000	USD
	pen	Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction	1149000	USD
	pen	Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction	0	USD
	pen	Writeoffof Note Receivable WriteoffofNoteReceivable	91000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	308000	USD
CY2016Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	400000	USD
	pen	Writeoffof Note Receivable WriteoffofNoteReceivable	0	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2567000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3584000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29444000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36635000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25581000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33760000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1227000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5543000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	546000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	252087000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2893000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	275031000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	125975000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	97802000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	38214000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	129257000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1510000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5126000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4264000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10800000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	602000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	589000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	631000	USD
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	110000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1327750	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1327750	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3970638	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3970638	shares
CY2015Q4	us-gaap	Assets Assets	263848000	USD
CY2016Q3	us-gaap	Assets Assets	297279000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	244361000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	267223000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	14000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	175000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	269000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	129512000	USD
CY2016Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	125831000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	269000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	31000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	66274000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	31587000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	62983000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	94388000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-541000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	3000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2197000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3290000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	159098000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19547000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15856000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	155808000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3691000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2015Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1900000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3783000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1200000	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1809000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1800000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2016Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2700000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	30000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	598000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	60000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2119000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1618000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	111467000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	16919000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	44079000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	24313000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	65963000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-143000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	526000	USD
CY2016Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	345000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	10143000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	13394000	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	USD
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-339000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2373000	USD
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.568
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.659
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.013
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.218
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13653000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17519000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	300000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	35100000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y11M
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1257000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	7601000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1257000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7601000	USD
CY2016Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	56201000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	56761000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	33497000	USD
	us-gaap	Gross Profit GrossProfit	87600000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	42874000	USD
	us-gaap	Gross Profit GrossProfit	124249000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2084000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2148000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1092000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	646000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1183000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1416000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	787000	USD
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	606000	USD
CY2016Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5104000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1501000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	947000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7383000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7088000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5901000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8796000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18012000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14018000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1706000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	17000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	402000	USD
CY2016Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	631000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1700000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	44839000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	70092000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9176000	USD
CY2016Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10900000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2746000	USD
CY2016Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2991000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	704000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1190000	USD
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2300000	USD
CY2016Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3800000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	31326000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	43425000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	263848000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	297279000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28148000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	37344000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125194000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12253000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	43584000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3520000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12631000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10051000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	901000	USD
	us-gaap	Net Income Loss NetIncomeLoss	732000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-1106000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-141000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	276000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	175000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1106000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-141000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	276000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	175000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1106000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-141000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015Q3	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-303000	USD
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-1018000	USD
CY2016Q3	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-1013000	USD
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-1475000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	31315000	USD
	us-gaap	Operating Expenses OperatingExpenses	85241000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	44237000	USD
	us-gaap	Operating Expenses OperatingExpenses	124447000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2182000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2359000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1363000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-198000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5273000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6497000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1304000	USD
CY2016Q3	us-gaap	Other Assets Current OtherAssetsCurrent	5004000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	393000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	438000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	220000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-115000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	254000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-303000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-892000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-898000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1731000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-24000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-152000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1013000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1477000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-66000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	144000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-303000	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	314000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	713000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	46081000	USD
CY2016Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1138000	USD
CY2016Q3	us-gaap	Prepaid Taxes PrepaidTaxes	3321000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	125916000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3178000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6081000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-115000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-613000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-360000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-856000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2525000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2024000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4069000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	45027000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4507000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7078000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9352000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18665000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4706000	USD
CY2016Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5236000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	2736000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	52160000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2504000	USD
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	713000	USD
CY2016Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1138000	USD
CY2015	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	353000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	469000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14022000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23089000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8951000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16224000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-108000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-13000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	152000	USD
CY2015Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	5000	USD
CY2016Q3	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	0	USD
CY2015Q3	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	0	USD
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-541000	USD
CY2016Q3	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-1000	USD
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	3000	USD
CY2015Q3	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.45
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72698000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	67187000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	190212000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26755000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	37740000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106685000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5126000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10800000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15925	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3755345	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2906739	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.13
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.58
CY2016Q3	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	2000	USD
CY2015Q3	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	USD
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-195000	USD
CY2016Q3	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-1000	USD
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	1000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4560000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12543000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6497000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17762000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17475000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17616000	USD
CY2015Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	531000	USD
CY2016Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	578000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	50416000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	131679000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.90
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	148354	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	832681	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3800000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	232522000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	253854000	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	625000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	557000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	625000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	557000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10189248	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8494651	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30269463	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30604384	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30269463	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7853730	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5962031	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30604384	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;">Organization and Description of Business </font></div><div style="line-height:120%;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Penumbra, Inc. (the “Company”) is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The Company has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across </font><font style="font-family:Times New Roman;font-size:10pt;">two</font><font style="font-family:Times New Roman;font-size:10pt;"> major markets, neuro and peripheral vascular. The conditions that the Company’s products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and equity accounts; disclosure of contingent assets and liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to marketable investments, provisions for doubtful accounts, sales return reserve, warranty reserves, valuation of inventories, useful lives of property and equipment, income taxes, and contingencies, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other data. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001321732-16-000089-index-headers.html	Edgar Link	pending
0001321732-16-000089-index.html	Edgar Link	pending
0001321732-16-000089.txt	Edgar Link	pending
0001321732-16-000089-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pen-093016x10q.htm	Edgar Link	pending
pen-093016xexhibit311.htm	Edgar Link	pending
pen-093016xexhibit312.htm	Edgar Link	pending
pen-093016xexhibit321.htm	Edgar Link	pending
pen-20160930.xml	Edgar Link	completed
pen-20160930.xsd	Edgar Link	pending
pen-20160930_cal.xml	Edgar Link	unprocessable
pen-20160930_def.xml	Edgar Link	unprocessable
pen-20160930_lab.xml	Edgar Link	unprocessable
pen-20160930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PEN
Penumbra Inc Stock $pen

2016 Q3 Form 10-Q Financial Statement

#000132173216000089 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEN Penumbra Inc Stock $pen

2016 Q3 Form 10-Q Financial Statement

#000132173216000089 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEN
Penumbra Inc Stock $pen